Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs). This article serves as a summary of the guideline on the appropriate use of tigecycline, published in mid-2010 as a collaborative effort by representatives of the Association of Surgeons of South Africa, the Critical Care Society of Southern Africa, the Federation of Infectious Diseases Societies of Southern Africa, the South African Thoracic Society and the Trauma Society of South Africa.

Citation

A J Brink, D Bizos, K D Boffard, C Feldman, D C Grolman, J Pretorius, G A Richards, E Steyn. Guideline summary: appropriate use of tigecycline. South African journal of surgery. Suid-Afrikaanse tydskrif vir chirurgie. 2012 Feb;50(1):20-1

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22353316

View Full Text